CISPLATIN

Generic: CISPLATIN

Teva Parenteral MedicinesManufacturer
INTRAVENOUSRoute
CISPLATINActive Substance
2000-05-16Original Approval

CISPLATIN is FDA application ANDA074656, sponsored by PHARMACHEMIE BV. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Class II2024-10-01
Cisplatin Injection, 100mg/100mL (1mg/mL), For Intravenous Use, 100 mL Multiple Dose Vial, Rx Only, Manufactured for: Ac

Failed Impurities/Degradation Specifications.

Top Reported Reactions

1
OFF LABEL USE
5,885 reports
2
NAUSEA
5,438 reports
3
NEUTROPENIA
4,876 reports
4
DISEASE PROGRESSION
4,658 reports
5
FEBRILE NEUTROPENIA
4,607 reports
6
VOMITING
4,566 reports
7
ANAEMIA
4,050 reports
8
THROMBOCYTOPENIA
3,787 reports
9
DIARRHOEA
3,759 reports
10
PYREXIA
3,398 reports